Related Experiment Video
Updated: Jun 9, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
Outcomes following off-site remote systemic cancer therapy administration
Abram S Arnold1,2, Samia Asif2, Valerie Shostrom3
1Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, Nebraska, USA.
Teleoncology provides effective cancer care for rural veterans, with remote sites showing similar outcomes to the primary site. This model improves access to essential oncology services.
Area of Science:
- Oncology
- Health Services Research
- Telemedicine
Background:
- Veterans Affairs Nebraska Western Iowa Health Care System (VA-NWIHCS) extends cancer care to rural veterans using teleoncology.
- Remote systemic cancer therapy services are offered at Lincoln and Grand Island sites.
Purpose of the Study:
- To compare clinical outcomes of patients receiving cancer care at remote teleoncology sites versus the primary Omaha site.
- To evaluate the effectiveness of remote systemic cancer therapy delivery.
Main Methods:
- Retrospective review of 151 patients receiving first-line systemic therapy between January 2018 and December 2020.
- Analysis included demographics, cancer type/stage, survival, treatment details, toxicities, and healthcare utilization.
- Statistical analysis performed using SAS version 9.4.
Main Results:
- 108 patients treated in Omaha, 43 at remote sites; predominantly male, median age 69, ECOG PS 0-1.
- Groups were comparable in comorbidities, cancer types, stage IV disease proportion, and curative intent.
- No significant differences observed in 1- and 2-year survival, treatment toxicity, cycle delays, or hospitalizations.
Conclusions:
- Teleoncology provides comparable oncology care outcomes to in-person treatment.
- Remote systemic cancer therapy delivery is effective and can improve access to care for rural veterans.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy